Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral N-Acetyl Cysteine vs Rectal Diclofenac for Prevention of Post-ERCP Pancreatitis
NCT06252441Phase 2Completed
- Sponsor
- Tanta University
- Start
- Mar 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Tanta University. Started Mar 2024; status: completed.
02
Drugs
acetylcysteine
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT06252441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06252441.